hotspot
Previous article:
DIEP, the 'gold standard' of breast reconstruction, is under threat
Next article: In boost for rare disease push, AstraZeneca to buy Amolyt Pharma
Next article: In boost for rare disease push, AstraZeneca to buy Amolyt Pharma
hotspot
focus
-
How to save health care price transparency rules
2025-09-28 21:09 -
WuXi out of biotech trade group, U.S. and China relations to blame
2025-09-28 20:25 -
Pushing for an NIH office for post
2025-09-28 19:49 -
Why depression after traumatic brain injury is distinct
2025-09-28 19:45 -
Amylyx ALS drug fails trial: Relyvrio patients react with fear, worry
2025-09-28 19:23 -
Clinical trials must include more disabled people
2025-09-28 18:31